• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: November 22-26, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

November 22 - 26, 2010
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/23/10Silver Spring, MDJoshua Sharfstein, Molly Muldoon, Jeff Shuren, Peter Beckerman, Michelle DiFilippo
Thomas Kalil (Executive Office of the President);
Mary Saunders (International Trade Administration);
Marc Berejka (U.S. Department of Commerce);
Richard Paddock, (International Trade Administration)
The medical technology sector and continuing collaboration
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Russell Abbott, Deputy Commissioner for Administration11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine11/23/10Rockville, MDJonathan Baker, Dorothy McAdams, Vernon Toelle, Marilyn Martinez, Mai Huynh, Anna Nevius, Matthew Lucia, Thomas Moskal, Tom Modric, Mary Allen, Angela ClarkeMichael Apley (Kansas State University)Drug approval process
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health11/22/10-11/26/10N/AN/AN/ANo Signifcant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Beth Martino, Associate Commissioner for External Affairs11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health11/22/10Silver Spring, MDCatherine Norcio, Foreman, Alberto Gutierrez, Rachel Turow, Philip Desjardins, Don St.PierreHans Beinke, Tom Connaughton, Jim Dennison, Steve Ferguson, Dave Fisher, Elisabeth George, Don Gerhardt, Todd Gillenwater, Rick Naples, Campbell Rogers, Pam Schaub, Vince Ventimiglia (B&D Consulting)  Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health11/24/10Silver Spring, MDMichelle McMurry-HeathMarc Boutin (National Health Council)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel11/24/10Silver Spring, MDSonal Vaid, Seth Ray, Jane AxelradMarc Goshko, Donald Stark (TEVA North America)Drug Approval
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs11/22/10-11/26/10N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research11/22/10-11/26/10N/AN/AN/ANo Significant Meetings